Jon Stonehouse was appointed Chief Executive Officer and a member of the Board of Directors of BioCryst Pharmaceuticals on January 8, 2007.
Jon Stonehouse was appointed Chief Executive Officer and a member of the Board of Directors of BioCryst Pharmaceuticals on January 8, 2007. BioCryst Pharmaceuticals is a company that develops product candidates for leukemia, inflammatory and infectious diseases. Before joining BioCryst, he served as Senior Vice President of Corporate Development at Merck KGaA, with responsibilities including global licensing, business development, mergers and acquisitions, and corporate strategic planning. He also previously worked at AstraZeneca and Merck & Co.
Full founder directory · Investor directory · Company funding database · Fundraising library